ANDAMERTINIB

UNII:	5X3KAG7ZBW
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₁H₃₆N₈O₃
Preferred Substance Name:	ANDAMERTINIB
InChIKey:	KKPCZGCBAIJCOU-UHFFFAOYSA-N
GSRS Full Record:	5X3KAG7ZBW i

2254145-43-0
2-Propenamide, N-[4-methoxy-2-[4-(3-methoxy-1-azetidinyl)-1-piperidinyl]-5-[[6-(1-methyl-1H-indazol-5-yl)-4-pyrimidinyl]amino]phenyl]-
Andamertinib
N-(4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-{[6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide
N-[4-Methoxy-2-[4-(3-methoxy-1-azetidinyl)-1-piperidinyl]-5-[[6-(1-methyl-1H-indazol-5-yl)-4-pyrimidinyl]amino]phenyl]-2-propenamide
N-[4-methoxy-2-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]-5-[[6-(1-methylindazol-5-yl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
andamertinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ANDAMERTINIB

Synonyms and Mappings

Resources